04:08 PM EDT, 07/18/2025 (MT Newswires) -- Cedric Francois, Director, Chief Executive Officer, on July 17, 2025, sold 19,725 shares in Apellis Pharmaceuticals ( APLS ) for $398,735. Following the Form 4 filing with the SEC, Francois has control over a total of 1,871,027 common shares of the company, with 331,605 shares held directly and 1,539,422 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000112760225019413/xslF345X05/form4.xml